Geoffrey Beran Rose - 03 Mar 2025 Form 4 Insider Report for Pulmonx Corp (LUNG)

Signature
/s/ David Aaron Lehman, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
03 Mar 2025
Net transactions value
-$41,193
Form type
4
Filing time
05 Mar 2025, 18:02:28 UTC
Previous filing
04 Dec 2024
Next filing
04 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $3,702 -520 -0.18% $7.12 290,537 03 Mar 2025 Direct F1
transaction LUNG Common Stock Sale $6,515 -915 -0.31% $7.12 289,622 03 Mar 2025 Direct F2
transaction LUNG Common Stock Sale $16,615 -2,327 -0.8% $7.14 287,295 03 Mar 2025 Direct F3
transaction LUNG Common Stock Sale $14,361 -2,017 -0.7% $7.12 285,278 03 Mar 2025 Direct F4
transaction LUNG Common Stock Award $0 +108,000 +38% $0.000000 393,278 03 Mar 2025 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F5 Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025.